JP2012504163A5 - - Google Patents

Download PDF

Info

Publication number
JP2012504163A5
JP2012504163A5 JP2011530087A JP2011530087A JP2012504163A5 JP 2012504163 A5 JP2012504163 A5 JP 2012504163A5 JP 2011530087 A JP2011530087 A JP 2011530087A JP 2011530087 A JP2011530087 A JP 2011530087A JP 2012504163 A5 JP2012504163 A5 JP 2012504163A5
Authority
JP
Japan
Prior art keywords
active agent
donepezil active
composition
sustained delivery
donepezil
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2011530087A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012504163A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2009/055542 external-priority patent/WO2010039381A1/en
Publication of JP2012504163A publication Critical patent/JP2012504163A/ja
Publication of JP2012504163A5 publication Critical patent/JP2012504163A5/ja
Pending legal-status Critical Current

Links

JP2011530087A 2008-09-30 2009-08-31 経皮持続送達ドネペジル組成物および該組成物を使用する方法 Pending JP2012504163A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10141208P 2008-09-30 2008-09-30
US61/101,412 2008-09-30
PCT/US2009/055542 WO2010039381A1 (en) 2008-09-30 2009-08-31 Transdermal extended-delivery donepezil compositions and methods for using the same

Publications (2)

Publication Number Publication Date
JP2012504163A JP2012504163A (ja) 2012-02-16
JP2012504163A5 true JP2012504163A5 (enExample) 2012-03-29

Family

ID=42057739

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011530087A Pending JP2012504163A (ja) 2008-09-30 2009-08-31 経皮持続送達ドネペジル組成物および該組成物を使用する方法

Country Status (12)

Country Link
US (1) US20100080842A1 (enExample)
EP (1) EP2328582A4 (enExample)
JP (1) JP2012504163A (enExample)
CN (1) CN102164601A (enExample)
AR (1) AR073696A1 (enExample)
AU (1) AU2009300184A1 (enExample)
BR (1) BRPI0917862A2 (enExample)
CA (1) CA2733265A1 (enExample)
IL (1) IL210970A0 (enExample)
MX (1) MX2011002260A (enExample)
TW (1) TW201029653A (enExample)
WO (1) WO2010039381A1 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ605352A (en) 2010-06-30 2013-10-25 Nal Pharmaceuticals Ltd Process for producing glycosaminoglycans
KR20140005151A (ko) * 2010-09-30 2014-01-14 세키스이 메디칼 가부시키가이샤 첩부제
TWI433904B (zh) * 2011-01-12 2014-04-11 Taiwan Biotech Co Ltd 多奈哌齊經皮貼片
WO2013078608A1 (en) 2011-11-29 2013-06-06 Ziqiang Gu Donepezil pamoate and methods of making and using the same
KR101485822B1 (ko) 2014-01-22 2015-01-23 주식회사 대웅제약 도네페질 또는 그의 염을 함유하는 경피흡수제제
US10195408B2 (en) 2014-02-20 2019-02-05 Nal Pharmaceutical Group Limited Transdermal drug delivery system containing donepezil
MY181540A (en) * 2014-12-18 2020-12-28 Icure Pharm Inc Transdermal composition containing donepezil as active ingredient
KR102033686B1 (ko) 2017-05-19 2019-10-18 보령제약 주식회사 도네페질을 함유하는 마이크로니들 경피 패치
WO2019118782A1 (en) * 2017-12-13 2019-06-20 Corium, Inc. Method for depot creation during transdermal drug delivery
KR102024996B1 (ko) 2017-12-27 2019-09-25 동아에스티 주식회사 도네페질을 함유하는 치매 치료용 경피흡수제제
KR102372630B1 (ko) 2019-05-15 2022-03-14 주식회사 대웅제약 고함량의 도네페질 또는 그의 염을 포함하는 경피흡수제제
CN112823793A (zh) * 2019-11-20 2021-05-21 成都康弘药业集团股份有限公司 一种含有多奈哌齐的透皮贴剂及其制备方法
TW202440102A (zh) * 2022-12-16 2024-10-16 日商帝國製藥股份有限公司 含多奈哌齊之經皮吸收製劑

Family Cites Families (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4880633A (en) * 1986-03-12 1989-11-14 Merck & Co., Inc. Transdermal drug delivery system
EP0249343B1 (en) * 1986-06-13 1992-01-08 Alza Corporation Moisture activation of transdermal drug delivery system
US5006342A (en) * 1986-12-22 1991-04-09 Cygnus Corporation Resilient transdermal drug delivery device
US5186939A (en) * 1987-04-23 1993-02-16 Cygnus Therapeutic Systems Laminated composite for transdermal administration of fentanyl
FI95572C (fi) * 1987-06-22 1996-02-26 Eisai Co Ltd Menetelmä lääkeaineena käyttökelpoisen piperidiinijohdannaisten tai sen farmaseuttisen suolan valmistamiseksi
US4849224A (en) * 1987-11-12 1989-07-18 Theratech Inc. Device for administering an active agent to the skin or mucosa
US5681579A (en) * 1993-03-22 1997-10-28 E.R. Squibb & Sons, Inc. Polymeric support wound dressing
US5613958A (en) * 1993-05-12 1997-03-25 Pp Holdings Inc. Transdermal delivery systems for the modulated administration of drugs
US5503844A (en) * 1993-05-18 1996-04-02 Mli Acquisition Corp. Ii Foam laminate transdermal patch
DE4341444C2 (de) * 1993-12-04 1996-03-14 Lohmann Therapie Syst Lts Wirkstoffhaltiges Pflaster und Verfahren zu seiner Herstellung
US5536263A (en) * 1994-03-30 1996-07-16 Lectec Corporation Non-occulusive adhesive patch for applying medication to the skin
US5635203A (en) * 1994-09-29 1997-06-03 Alza Corporation Transdermal device having decreased delamination
US5759560A (en) * 1995-07-27 1998-06-02 Bio Med Sciences, Inc. Silicone thermoplastic sheeting for scar treatment and useful article thereof; process of manufacture and use
US5906830A (en) * 1995-09-08 1999-05-25 Cygnus, Inc. Supersaturated transdermal drug delivery systems, and methods for manufacturing the same
TW513409B (en) * 1996-06-07 2002-12-11 Eisai Co Ltd Polymorphs of donepezil hydrochloride
US5716621A (en) * 1996-07-03 1998-02-10 Pharmadyn, Inc. Nonocclusive drug delivery device and process for its manufacture
US6007837A (en) * 1996-07-03 1999-12-28 Alza Corporation Drug delivery devices and process of manufacture
US6512010B1 (en) * 1996-07-15 2003-01-28 Alza Corporation Formulations for the administration of fluoxetine
CA2264687C (en) * 1996-10-24 2006-04-25 Alza Corporation Permeation enhancers for transdermal drug delivery compositions, devices, and methods
US7150881B2 (en) * 1997-06-26 2006-12-19 Mylan Technologies, Inc. Adhesive mixture for transdermal delivery of highly plasticizing drugs
US6197331B1 (en) * 1997-07-24 2001-03-06 Perio Products Ltd. Pharmaceutical oral patch for controlled release of pharmaceutical agents in the oral cavity
US6193993B1 (en) * 1998-03-03 2001-02-27 Eisai Co., Ltd. Suppository containing an antidementia medicament
DE19830649C2 (de) * 1998-07-09 2003-04-10 Lohmann Therapie Syst Lts Topisches Pflaster mit nichtsteroidalen Antirheumatika mit Säuregruppe
US6597946B2 (en) * 1998-11-09 2003-07-22 Transpharma Ltd. Electronic card for transdermal drug delivery and analyte extraction
US6611706B2 (en) * 1998-11-09 2003-08-26 Transpharma Ltd. Monopolar and bipolar current application for transdermal drug delivery and analyte extraction
US6148232A (en) * 1998-11-09 2000-11-14 Elecsys Ltd. Transdermal drug delivery and analyte extraction
WO2000033812A2 (en) * 1998-12-07 2000-06-15 Elan Corporation, Plc Transdermal patch for delivering volatile liquid drugs
US7273618B2 (en) * 1998-12-09 2007-09-25 Chiron Corporation Method for administering agents to the central nervous system
US7374779B2 (en) * 1999-02-26 2008-05-20 Lipocine, Inc. Pharmaceutical formulations and systems for improved absorption and multistage release of active agents
US7063859B1 (en) * 1999-04-28 2006-06-20 Noven Pharmaceuticals, Inc. Barrier film lined backing layer composition and method for topical administration of active agents
US6395300B1 (en) * 1999-05-27 2002-05-28 Acusphere, Inc. Porous drug matrices and methods of manufacture thereof
US6719997B2 (en) * 2000-06-30 2004-04-13 Dermatrends, Inc. Transdermal administration of pharmacologically active amines using hydroxide-releasing agents as permeation enhancers
US6673363B2 (en) * 1999-12-16 2004-01-06 Dermatrends, Inc. Transdermal and topical administration of local anesthetic agents using basic enhancers
DE60124730T2 (de) * 2000-03-03 2007-10-04 Eisai R&D Management Co., Ltd. Neue methoden unter verwendung von cholinesteraseinhibitoren
DE10060852A1 (de) * 2000-12-06 2002-06-20 Hexal Ag Absorptionsmittel und Kanalbildner enthaltende wirkstoffundurchlässige Deckschicht oder abziehbare Schutzschicht eines transdermalen therapeutischen Systems
US6589514B2 (en) * 2001-04-17 2003-07-08 Morinda, Inc. Cosmetic intensive repair serum with morinda citrifolia
US6833478B2 (en) * 2001-07-13 2004-12-21 Sri International N,N-dinitramide salts as solubilizing agents for biologically active agents
US6893655B2 (en) * 2001-10-09 2005-05-17 3M Innovative Properties Co. Transdermal delivery devices
WO2003032914A2 (en) * 2001-10-17 2003-04-24 Eisai Co., Ltd. Methods for treating substance abuse with cholinesterase inhibitors
JP4394443B2 (ja) * 2001-10-17 2010-01-06 久光製薬株式会社 経皮吸収型製剤
US6787682B2 (en) * 2001-11-05 2004-09-07 Hollister Incorporated Absorbent foam wound dressing
JP2004024724A (ja) * 2002-06-28 2004-01-29 Biopol Co Ltd 多層構造の微細多孔性フォームドレッシング材及びその製造方法
IL150509A (en) * 2002-07-01 2007-07-04 Joseph Kaspi Pharmaceutical preparations containing donafazil hydrochloride
CN1214785C (zh) * 2002-08-27 2005-08-17 孙丽琴 一种用于保护眼睛的透皮控穴位贴片及其制备方法
JP4792193B2 (ja) * 2002-08-28 2011-10-12 久光製薬株式会社 貼付剤
US7439365B2 (en) * 2003-11-17 2008-10-21 Usv, Ltd. Pharmaceutical salt of (1-benzyl-4-[(5,6-dimethoxy-1-indanone)-2-yl] methyl piperidine (Donepezil)
US7186842B2 (en) * 2003-02-12 2007-03-06 Usv, Ltd. Polymorph of (1-benzyl-4-[(5,6-dimethoxy-1-indanone)-2-y1] methyl piperidine hydrochloride (Donepezil hydrochloride) and a process for producing thereof
RS20060332A (sr) * 2003-10-28 2008-04-04 Noven Pharmaceuticals Inc., Kompozicije i postupci za kontrolisanje gubitka i oslobađanja leka u transdermalnim sistemima oslobađanja leka
US20080138388A1 (en) * 2005-02-04 2008-06-12 Hisamitsu Pharmaceutical Co., Inc. Transdermal Absorption Patch
CN101460156B (zh) * 2006-05-08 2011-06-08 帝国制药株式会社 抗痴呆药的经皮吸收制剂
JP5097359B2 (ja) * 2006-05-09 2012-12-12 久光製薬株式会社 ドネペジル経皮吸収型製剤
US9248104B2 (en) * 2006-08-17 2016-02-02 Core Tech Solutions, Inc. Transdermal methods and systems for treating Alzheimer's disease
BRPI0719308A2 (pt) * 2006-12-01 2014-02-04 Nitto Denko Corp Método para supressão da coloração de preparação adesiva contendo donepzil e método para redução da quantidade de substâncias formadas relacionadas à donepezil.
US20090297591A1 (en) * 2008-05-30 2009-12-03 Orient Pharma Co., Ltd. Compositions And Methods For The Transdermal Delivery Of Pharmaceutical Compounds
WO2013078608A1 (en) * 2011-11-29 2013-06-06 Ziqiang Gu Donepezil pamoate and methods of making and using the same

Similar Documents

Publication Publication Date Title
JP2012504163A5 (enExample)
JP7153010B2 (ja) 塩薬物のｉｎ ｓｉｔｕでの塩から中性の薬物変換による、低溶解度または不安定非イオン化中性薬物の経皮配合物および送達方法
JP5301190B2 (ja) 貼付剤
JP2019525932A5 (enExample)
NZ509216A (en) Topical plaster with non-steroidal antirheumatic agents with a free carboxyl group
JP2010510260A5 (enExample)
JPWO2004112760A1 (ja) 医療用経皮吸収テープ製剤用非水性粘着剤並びに医療用経皮吸収テープ製剤およびその製造法
JP6556873B2 (ja) 経皮吸収製剤
TW201236701A (en) Hydrous adhesive patch
AR073696A1 (es) Composiciones transdermicas de donepezilo de liberacion prolongada y metodos para utilizar las mismas.kits
WO2001062254A1 (fr) Pieces contenant de la buprenorphine chlorhydrate
JP2011523650A5 (enExample)
CA2616695A1 (en) Transdermal system for varenicline
WO2011118683A1 (ja) 医用貼付剤
WO2006048939A1 (ja) 非ステロイド消炎鎮痛薬を含有する非水系経皮吸収製剤
JP4881006B2 (ja) ツロブテロール貼付剤
JP4705343B2 (ja) 経皮吸収製剤用基剤およびこれを用いた皮膚貼付製剤
US20150209302A1 (en) Adhesive skin patch
JP4295467B2 (ja) 貼付剤およびその製造方法
WO2005049004A1 (ja) 貼付剤
JP2014028791A (ja) 貼付剤
JP5930877B2 (ja) 経皮吸収製剤
JP3201645B2 (ja) 投錨性を向上させた貼付剤
JP3046330B2 (ja) 貼付製剤
JP6488021B2 (ja) アクリル系粘着剤の流動化抑制方法